Skip to main content
Top
Published in: Strahlentherapie und Onkologie 9/2017

Open Access 01-09-2017 | Short Communication

An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer

Authors: M. Groher, P. Kopp, M. Drerup, H. Deutschmann, F. Sedlmayer, Dr. Frank Wolf, MD-PhD

Published in: Strahlentherapie und Onkologie | Issue 9/2017

Login to get access

Abstract

Purpose

Gold-marker-based image-guided radiation therapy (IGRT) of the prostate allows to correct for inter- and intrafraction motion and therefore to safely reduce margins for the prostate planning target volume (PTV). However, pelvic PTVs, when coadministered in a single plan (registered to gold markers [GM]), require reassessment of the margin concept since prostate movement is independent from the pelvic bony anatomy to which the lymphatics are usually referenced to.

Methods

We have therefore revisited prostate translational movement relative to the bony anatomy to obtain adequate margins for the pelvic PTVs compensating mismatch resulting from referencing pelvic target volumes to GMs in the prostate. Prostate movement was analyzed in a set of 28 patients (25 fractions each, totaling in 684 fractions) and the required margins calculated for the pelvic PTVs according to Van Herk’s margin formula \(M=2.5\Upsigma +1.64\left (\sigma^{\prime}-\sigma _{p}\right )\).

Results

The overall mean prostate movement relative to bony anatomy was 0.9 ± 3.1, 0.6 ± 3.4, and 0.0 ± 0.7 mm in anterior/posterior (A/P), inferior/superior (I/S) and left/right (L/R) direction, respectively. Calculated margins to compensate for the resulting mismatch to bony anatomy were 9/9/2 mm in A/P, I/S, and L/R direction and 10/11/6 mm if an additional residual error of 2 mm was assumed.

Conclusion

GM-based IGRT for pelvic PTVs is feasible if margins are adapted accordingly. Margins could be reduced further if systematic errors which are introduced during the planning CT were eliminated.
Footnotes
1
For average static field sizes in water a lower limit for \(\sigma _{p}\) of about 3.2 mm is used [16]. However, for larger fields and dynamic segments as used in our study we have derived a higher value of 5 mm.
 
Literature
1.
go back to reference Engels B, Soete G, Tournel K, Bral S, De Coninck P, Verellen D, Storme G (2009) Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity. Technol Cancer Res Treat 8(5):353–359CrossRefPubMed Engels B, Soete G, Tournel K, Bral S, De Coninck P, Verellen D, Storme G (2009) Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity. Technol Cancer Res Treat 8(5):353–359CrossRefPubMed
2.
go back to reference Fonteyne V, Lumen N, Ost P, Van Praet C, Vandecasteele K, De Gersem Ir W, Villeirs G, De Neve W, Decaestecker K, De Meerleer G (2013) Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3‑year clinical outcome. Radiother Oncol 109(2):229–234. doi:10.1016/j.radonc.2013.08.006 CrossRefPubMed Fonteyne V, Lumen N, Ost P, Van Praet C, Vandecasteele K, De Gersem Ir W, Villeirs G, De Neve W, Decaestecker K, De Meerleer G (2013) Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3‑year clinical outcome. Radiother Oncol 109(2):229–234. doi:10.​1016/​j.​radonc.​2013.​08.​006 CrossRefPubMed
3.
go back to reference Kawamura H, Murata K, Takakusagi Y, Okonogi N, Kubo N, Mizukami T, Sato H, Adachi AN, Saitoh JI, Fukuma Y, Hatori M, Ohtake N, Sekihara T, Ando Y, Matsui H, Ito K, Suzuki K, Nakano T (2016) Simultaneous integrated boost intensity modulated radiation therapy for clinically node-positive prostate cancer. Int J Radiat Oncol Biol Phys 96(2S):E243–E244. doi:10.1016/j.ijrobp.2016.06.1235 CrossRef Kawamura H, Murata K, Takakusagi Y, Okonogi N, Kubo N, Mizukami T, Sato H, Adachi AN, Saitoh JI, Fukuma Y, Hatori M, Ohtake N, Sekihara T, Ando Y, Matsui H, Ito K, Suzuki K, Nakano T (2016) Simultaneous integrated boost intensity modulated radiation therapy for clinically node-positive prostate cancer. Int J Radiat Oncol Biol Phys 96(2S):E243–E244. doi:10.​1016/​j.​ijrobp.​2016.​06.​1235 CrossRef
4.
go back to reference Hocht S, Aebersold DM, Albrecht C, Bohmer D, Flentje M, Ganswindt U, Holscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T (2017) Hypofractionated radiotherapy for localized prostate cancer. Strahlenther Onkol 193(1):1–12. doi:10.1007/s00066-016-1041-5 CrossRefPubMed Hocht S, Aebersold DM, Albrecht C, Bohmer D, Flentje M, Ganswindt U, Holscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T (2017) Hypofractionated radiotherapy for localized prostate cancer. Strahlenther Onkol 193(1):1–12. doi:10.​1007/​s00066-016-1041-5 CrossRefPubMed
5.
go back to reference Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, Vijayakumar S, Chen GT (1995) Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 33(5):1321–1329. doi:10.1016/0360-3016(95)00225-1 CrossRefPubMed Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, Vijayakumar S, Chen GT (1995) Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 33(5):1321–1329. doi:10.​1016/​0360-3016(95)00225-1 CrossRefPubMed
6.
go back to reference Schild SE, Casale HE, Bellefontaine LP (1993) Movements of the prostate due to rectal and bladder distension: implications for radiotherapy. Med Dosim 18(1):13–15CrossRefPubMed Schild SE, Casale HE, Bellefontaine LP (1993) Movements of the prostate due to rectal and bladder distension: implications for radiotherapy. Med Dosim 18(1):13–15CrossRefPubMed
8.
go back to reference Hinton BK, Fiveash JB, Wu X, Dobelbower MC, Kim RY, Jacob R (2013) Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients. ISRN Oncol 2013:941269. doi:10.1155/2013/941269 PubMedPubMedCentral Hinton BK, Fiveash JB, Wu X, Dobelbower MC, Kim RY, Jacob R (2013) Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients. ISRN Oncol 2013:941269. doi:10.​1155/​2013/​941269 PubMedPubMedCentral
9.
go back to reference Polat B, Guenther I, Wilbert J, Goebel J, Sweeney RA, Flentje M, Guckenberger M (2008) Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol 184(12):668–673. doi:10.1007/s00066-008-1875-6 CrossRefPubMed Polat B, Guenther I, Wilbert J, Goebel J, Sweeney RA, Flentje M, Guckenberger M (2008) Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol 184(12):668–673. doi:10.​1007/​s00066-008-1875-6 CrossRefPubMed
11.
go back to reference Li M, Ballhausen H, Hegemann NS, Reiner M, Tritschler S, Gratzke C, Manapov F, Corradini S, Ganswindt U, Belka C (2016) Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT. Strahlenther Onkol. doi:10.1007/s00066-016-1084-7 Li M, Ballhausen H, Hegemann NS, Reiner M, Tritschler S, Gratzke C, Manapov F, Corradini S, Ganswindt U, Belka C (2016) Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT. Strahlenther Onkol. doi:10.​1007/​s00066-016-1084-7
12.
13.
14.
go back to reference McDonald AM, Baker CB, Popple RA, Shekar K, Yang ES, Jacob R, Cardan R, Kim RY, Fiveash JB (2014) Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiat Oncol 9:129. doi:10.1186/1748-717X-9-129 CrossRefPubMedPubMedCentral McDonald AM, Baker CB, Popple RA, Shekar K, Yang ES, Jacob R, Cardan R, Kim RY, Fiveash JB (2014) Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiat Oncol 9:129. doi:10.​1186/​1748-717X-9-129 CrossRefPubMedPubMedCentral
16.
go back to reference van Herk M, Remeijer P, Rasch C, Lebesque JV (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47(4):1121–1135CrossRefPubMed van Herk M, Remeijer P, Rasch C, Lebesque JV (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47(4):1121–1135CrossRefPubMed
17.
go back to reference Wolf F, Gaisberger C, Ziegler I, Krenn E, Scherer P, Hruby S, Schatz T, Forstner R, Holzinger J, Vaszi A, Kametriser G, Steininger P, Deutschmann H, Sedlmayer F (2015) Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency. Radiother Oncol. doi:10.1016/j.radonc.2015.07.027 Wolf F, Gaisberger C, Ziegler I, Krenn E, Scherer P, Hruby S, Schatz T, Forstner R, Holzinger J, Vaszi A, Kametriser G, Steininger P, Deutschmann H, Sedlmayer F (2015) Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency. Radiother Oncol. doi:10.​1016/​j.​radonc.​2015.​07.​027
18.
go back to reference Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O’Meara E, Rosenthal SA, Ritter M, Seider M (2009) RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 74(2):383–387. doi:10.1016/j.ijrobp.2008.08.002 CrossRefPubMed Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O’Meara E, Rosenthal SA, Ritter M, Seider M (2009) RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 74(2):383–387. doi:10.​1016/​j.​ijrobp.​2008.​08.​002 CrossRefPubMed
19.
go back to reference Deutschmann H, Kametriser G, Steininger P, Scherer P, Scholler H, Gaisberger C, Mooslechner M, Mitterlechner B, Weichenberger H, Fastner G, Wurstbauer K, Jeschke S, Forstner R, Sedlmayer F (2012) First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 83(5):1624–1632CrossRefPubMed Deutschmann H, Kametriser G, Steininger P, Scherer P, Scholler H, Gaisberger C, Mooslechner M, Mitterlechner B, Weichenberger H, Fastner G, Wurstbauer K, Jeschke S, Forstner R, Sedlmayer F (2012) First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 83(5):1624–1632CrossRefPubMed
20.
go back to reference Rosewall T, Yan J, Alasti H, Cerase C, Bayley A (2016) ‘Compromise position’ image alignment to accommodate independent motion of multiple clinical target volumes during radiotherapy: A high risk prostate cancer example. J Med Imaging Radiat Oncol. doi:10.1111/1754-9485.12543 PubMed Rosewall T, Yan J, Alasti H, Cerase C, Bayley A (2016) ‘Compromise position’ image alignment to accommodate independent motion of multiple clinical target volumes during radiotherapy: A high risk prostate cancer example. J Med Imaging Radiat Oncol. doi:10.​1111/​1754-9485.​12543 PubMed
21.
22.
go back to reference Eminowicz G, Dean C, Shoffren O, Macdougall N, Wells P, Muirhead R (2014) Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy? Br J Radiol 87(1037):20130696. doi:10.1259/bjr.20130696 CrossRefPubMedPubMedCentral Eminowicz G, Dean C, Shoffren O, Macdougall N, Wells P, Muirhead R (2014) Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy? Br J Radiol 87(1037):20130696. doi:10.​1259/​bjr.​20130696 CrossRefPubMedPubMedCentral
23.
go back to reference Crook JM, Raymond Y, Salhani D, Yang H, Esche B (1995) Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37(1):35–42CrossRefPubMed Crook JM, Raymond Y, Salhani D, Yang H, Esche B (1995) Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37(1):35–42CrossRefPubMed
Metadata
Title
An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer
Authors
M. Groher
P. Kopp
M. Drerup
H. Deutschmann
F. Sedlmayer
Dr. Frank Wolf, MD-PhD
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 9/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1182-1

Other articles of this Issue 9/2017

Strahlentherapie und Onkologie 9/2017 Go to the issue